CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders.
CarThera has raised $4.8M in total funding. The most recent round was Series B. The last funding was announced in December 2023.
CarThera's investors include Supernova Invest, Panakes Partners, European Innovation Council, AGORANOV, Unorthodox Ventures.
CarThera is headquartered in Paris, France.
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders.
CarThera is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CarThera — Funding & Investors." VCBacked, December 11, 2023, https://www.vcbacked.co/company/carthera. Accessed July 19, 2026.
VCBacked. (2023). CarThera — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/carthera
{{cite web |title=CarThera — Funding & Investors |url=https://www.vcbacked.co/company/carthera |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated